Department of Ophthalmology and Visual Sciences, University of Louisville School of Medicine, Louisville, KY 40202, USA.
Eye Contact Lens. 2010 Sep;36(5):249-53. doi: 10.1097/ICL.0b013e3181ef0d37.
To recount the historic evaluation of meibomian gland dysfunction (MGD) and describe new techniques to monitor disease and therapy.
A review of the literature regarding the description of MGD and the role of abnormalities of meibomian gland secretion in health and disease.
Meibomian gland dysfunction is a common clinical condition and is a major cause of evaporative dry eye with associated discomfort, visual disturbance, and contact lens intolerance. Despite the early description of the anatomy and physiology of the meibomian gland, recognition of the importance of the MGD and particularly therapeutic options to treat it has been limited.
Improved methods of spectroscopic and chemical analysis of the meibomian gland secretion in health and disease are providing a better understanding of the physical and chemical abnormalities of the meibomian gland secretions and are allowing better evaluation of medical therapies.
回顾睑板腺功能障碍 (MGD) 的历史评估,并描述监测疾病和治疗的新技术。
对有关 MGD 描述以及睑板腺分泌异常在健康和疾病中的作用的文献进行综述。
睑板腺功能障碍是一种常见的临床病症,是与不适、视觉障碍和隐形眼镜不耐受相关的蒸发性干眼症的主要原因。尽管早期对睑板腺的解剖和生理学进行了描述,但对 MGD 的重要性以及治疗它的治疗选择的认识一直受到限制。
在健康和疾病中对睑板腺分泌物进行光谱和化学分析的改进方法提供了对睑板腺分泌物的物理和化学异常更好的理解,并允许对医学治疗进行更好的评估。